About SCI Ventures
SCI Ventures is a venture capital firm founded in 2024. It is primarily based out of London, United Kingdom. As of Sep 2026, SCI Ventures is an active investor, having invested in 5 companies, with 2 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and FinTech. Most recently it participated in the $***** Series A round of ViaNautis A lot of funds co-invest with SCI Ventures, with names like Andera Partners sharing a substantial percentage of its portfolio. SCI Ventures has team of 15 people including 4 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 1 more
Portfolio Soonicorns
Deals in last 12 months
SCI Ventures' List of All Investments
SCI Ventures has a portfolio of 5 companies. Their most notable investmentis in Precision NeuroscienceTheir portfolio spans across United States, France, Switzerland and 1 more locations. They have invested in Life Sciences, High Tech, FinTech and 2 other sectors, across stages such as Series A, Series B and 1 more. Here is the list of all investments by SCI Ventures:
Developed of brain-computer interface tool for medical treatment and drug development. The company has developed a next-generation brain computing technology that has the ability to process medicine and computing. The brain implants have features for AI-based computing, device integration, and assessment of neurological illness for medicine development.
Key facts about Precision Neuroscience
2. OrangeX
Cryptocurrency exchange and trading platform. It offers a platform that allows users to trade crypto derivatives and buy cryptocurrencies. It enables users to trade in markets like spots, perpetual, futures, and more. It also offers copy trading solutions and cryptocurrency conversions. Its app is available for Android and iOS users.
Key facts about OrangeX
- Founded Year: 2021
- Location: Bern (Switzerland)
- Stage: Series B
- Total Funding till date: $30M
- Employee Count: 34 as on Sep 30, 2026
- Investors: SCI Ventures, NGC Capital and 1 Other
- Latest Funding Round: Series B, Aug 28, 2025, $*****
- Highlight: Editors' Pick
3. ViaNautis
Developer of targeted nanomedicines for drug delivery. The company utilizes proprietary technology "polyNaut" that can be formulated to encapsulate a wide array of genetic cargoes for viral and non-viral delivery for CNS diseases and cystic fibrosis.
Key facts about ViaNautis
- Founded Year: 2018
- Location: Cambridge (United Kingdom)
- Stage: Series A
- Total Funding till date: $25M
- Employee Count: 42 as on Aug 31, 2026
- Investors: Origin Capital, 4Bio Capital and 8 Others
- Latest Funding Round: Series A, Sep 09, 2026, $*****
- Highlight: Editors' Pick
4. EG 427
Developer of gene therapies for neurogenic bladder. The company has an HSV-1 vector platform for the delivery and expression of a transgene encoding the light chain of botulinum toxin F in sensory neurons to treat neurogenic bladder after spinal cord injury, overactive bladder, and Interstitial cystitis.
Key facts about EG 427
- Founded Year: 2020
- Location: Paris (France)
- Stage: Series B
- Total Funding till date: $48.2M
- Employee Count: 25 as on Jun 30, 2026
- Investors: Andera Partners, SCI Ventures and 1 Other
- Latest Funding Round: Series B, Feb 20, 2025, $*****
- Highlight: Editors' Pick
Key facts about AXONIS Therapeutics
- Founded Year: 2011
- Location: Cambridge (United States)
- Stage: Series A
- Total Funding till date: $124M
- Employee Count: 29 as on Sep 30, 2026
- Investors: Perceptive Advisors, VenBio and 22 Others
- Latest Funding Round: Grant (prize money), Jun 25, 2025, $*****
SCI Ventures' Year-on-Year Investment Trends
In 2025, it made 3 investments, while as of Sep 2026, it has made 1 investment in this year. Its most recent first time investment was in ViaNautis.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 3 | 0 | 3 |
2024 | 1 | 0 | 1 |
SCI Ventures' Investments by Stage
SCI Ventures has made 2 investments in Series A stage with an average round size of $115M, 2 investments in Series B stage with an average round size of $24.1M and 1 investment in Series C stage.Stage of entry | No. of Investments |
|---|---|
Series A | 2 |
Series B | 2 |
Series C | 1 |
Note: We have considered here, only first round of investments
SCI Ventures' Investments by Sector
SCI Ventures has a diverse portfolio, with companies operating in the Life Sciences, Blockchain - Industry Applications, Blockchain Technology, FinTech and Healthcare. Notably, it has invested in 4 Tech companies, 3 Enterprise (B2B) companies, 1 Blockchain company and at least 1 company focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 3 |
Blockchain - Industry Applications | 1 |
Blockchain Technology | 1 |
FinTech | 1 |
Healthcare | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
SCI Ventures' Investments by Geography
SCI Ventures has made most investments in United States (2), followed by France where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 2 |
France | 1 |
Switzerland | 1 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
SCI Ventures' recent investments
SCI Ventures has made 1 investments in 2026 so far - ViaNautis.Here are the most recent investments by SCI Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 09, 2026 | United Kingdom | Series A | 5157 | - | |
Nov 05, 2025 | United States | Series C | 3201 | - | |
Aug 28, 2025 | Switzerland | Series B | 9343 | ||
Feb 20, 2025 | France | Series B | 8811 | [+1] | |
Oct 18, 2024 | United States | Series A | 5682 |
Team profile of SCI Ventures
SCI Ventures has a team of 15 members including 4 Partners and 2 Principals located in United Kingdom, United States and 1 more location. SCI Ventures' team does not sit on the board of any company as of now.Here is a list of top team members in SCI Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | United Kingdom | - | ||
Partner | - | - | ||
Partner | Atlanta | - | ||
Partner | Salzburg | - | ||
Principal | London | - | ||
Principal | London | - |
Co-investors of SCI Ventures
Over the past 2 years, 52 investors have co-invested in SCI Ventures's portfolio companies. This includes funds and angels.
- Invested before SCI Ventures: Steadview, B Capital and 27 others have invested in rounds before SCI Ventures. There is 1 company where Steadview has invested before SCI Ventures and 1 company where B Capital has invested before SCI Ventures.
- Top Co-investors of SCI Ventures: 14 investors entered a company along with SCI Ventures. These include investors like Andera Partners (1 company).
- Invested after SCI Ventures: A total of 9 investors have invested in SCI Ventures's portfolio after their investments. Top Investors include PERSHING SQUARE (1 company), ARK Investment Management (1 company) and Invus (1 company).
Recent News related to SCI Ventures
•
ViaNautis Bio Secures Investment from SCI Ventures to Advance Spinal Cord Injury TherapiesBusiness Insider•Sep 09, 2026•SCI Ventures, ViaNautis
•
Precision Neuroscience and SCI Ventures Partner to Bring Brain–Computer Interfaces to People Living with ParalysisGlobeNewswire•Nov 05, 2025•SCI Ventures, Precision Neuroscience
•
OrangeX Completes $20 Million Series B Financing RoundBitcoin Ethereum News•Aug 30, 2025•SCI Ventures, OrangeX, Kryptos, Kryptos
•
EG 427 secures €27M Series B funding for clinical trials and platform growth.Benzinga•Feb 20, 2025•EG 427, Andera Partners, Bpifrance, SCI Ventures and 3 others
•
Axonis Therapeutics: $115 Million (Series A) Raised To Develop Novel NeuromedicinesPulse 2.0•Nov 08, 2024•AXONIS Therapeutics, Sofinnova Investments, MRLV, Perceptive Advisors and 19 others
•
SCI Ventures Launches Venture Philanthropy Fund to Accelerate Restorative Treatments for Spinal Cord Injury and a Cure for ParalysisPR Newswire•Jun 10, 2024•SCI Ventures
